10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Thursday, 2024-02-15. Here’s what investors need to know before the announcement.
Analysts estimate that 10x Genomics will report an earnings per share (EPS) of $-0.36.
10x Genomics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
Last quarter the company beat EPS by $0.02, which was followed by a 8.73% increase in the share price the next day.
Here’s a look at 10x Genomics’s past performance and the resulting price change:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.46 | -0.39 | -0.37 | -0.31 |
| EPS Actual | -0.44 | -0.53 | -0.44 | -0.15 |
| Price Change % | 8.73% | -4.19% | 1.3% | 11.15% |
Stock Performance
Shares of 10x Genomics were trading at $46.78 as of February 13. Over the last 52-week period, shares are down 6.47%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for 10x Genomics visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
